-
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
21 Mar 2024 04:56 GMT
… plus temsirolimus or ixabepilone, carboplatin and bevacizumab … and tumor tissue targeting (drug accumulation in tumor tissue … Treatment for Advanced Endometrial Cancer: the Phase III DUO-E Trial … Engineering of Medicinal Chemistry for Cancer Therapy: recent …
-
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges
23 Feb 2024 13:20 GMT
… al164 proposed a pharmaceutical-organic-inorganic self- … drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment. Cancer … barriers to drug delivery. Nat Biotechnol. 2015;33 … per week or ixabepilone with bevacizumab as …
-
Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic
05 Dec 2023 12:30 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in …
-
Wyn Drabble: Pharmaceutical nomenclature – is there a remedy?
20 Sep 2023 02:01 GMT
… Drabble asks why most medication has such complicated … company.
Cisplatin, a chemotherapy cancer drug, has the word splat … Among them were idarucizumab, ixabepilone and eszopiclone (see glossary). … packaging of so many pharmaceuticals with their almost …
-
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
24 Jul 2023 10:00 GMT
… Corporate Controller at Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT … 3 in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … clinical tumor biology filters and prior clinical trial outcomes. … clinical outcome from drug treatment in cancer patients in 37 …
-
Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients
05 Jul 2023 13:45 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in …
-
Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib and Stenoparib Combination in Advanced Solid Tumors
20 Mar 2023 10:00 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in … renal cancer through Phase 3; and IXEMPRA® (Ixabepilone), …
-
Table of Pharmacogenomic Biomarkers in Drug Labeling
08 Feb 2023 22:07 GMT
… Pharmacology
Dexlansoprazole
Gastroenterology
CYP2C19
Drug Interactions, Clinical Pharmacology
… Clinical Pharmacology, Clinical Studies
Ixabepilone (1)
Oncology
ERBB2
(HER2 …
Pembrolizumab (6)
Oncology
Tumor Mutational Burden
Indications and Usage …
-
Treating metastatic breast cancer: What to know
23 Jan 2023 16:23 GMT
… drug treatment a person receives. However, all types of hormone therapy for cancer … chemotherapy drugs for metastatic breast cancer include:
taxanes
ixabepilone
eribulin
anthracyclines … tumors, but if a systemic treatment is working to control them, a doctor …
-
What medications are available to treat breast cancer?
31 Jan 2023 19:23 GMT
… cancer, preventive medications, and medications for those in remission.
The first-line treatment … clinical trial is … drugs, including:
eribulin (Halaven)
capecitabine
vinorelbine (Navelbine)
gemcitabine (Gemzar)
Ixabepilone … pharmaceutical company of the drug …